Browse > Article
http://dx.doi.org/10.15207/JKCS.2018.9.12.207

The using practices of antipsychotics for people with intellectual disabilities in Japan  

Kim, Mi-SuK (Special Education, Teachers College, Baekseok University)
Publication Information
Journal of the Korea Convergence Society / v.9, no.12, 2018 , pp. 207-216 More about this Journal
Abstract
In Korea, there has been no national research on the use of antipsychotics for people with intellectual disabilities(I.D); therefore, it is difficult to identify the problems or to find solutions for problems in using antipsychotics. So, the purpose of this study analyze research findings on the use of antipsychotics for people with I.D in Japan. This research method compared and analyzed the results of research published in the journal J-STAGE and Medical Online and studied a cohort results using data. The results of the analysis are as follows. First, many antipsychotic drugs are prescribed to people with I.D, but it is difficult to accurately assess the effectiveness of the treatments. Second, it is not easy to detect side effects. Third, the potential side effects of drug interactions have been raised. The results was emphasized the need of research that accurately evaluate the drugs in survey of actual situation to ensure more safe use of antipsychotics to peoples with I.D in Korea.
Keywords
antipsychotic drugs; people with intellectual disabilities; J-STAGE; Medical Online; cohort;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 K M. Chitty et al. (2016). Central nervous system medication use in older adults with intellectual disability: Results from the successful ageing in intellectual disability study. Aust NZJ Psychiatry, 50(4), 352-362.   DOI
2 S. L. Einfeld et al. (2011). Comorbidity of intellectual disability and mental disorder in children and adolescents: a systematic review. J Intellect Dev Disabil., 36(2), 137-143.   DOI
3 Y. H. Kang. (2008). Encyclopedia of Life Science. Academy Books.
4 M. A Song & H. J. Hong. (2013). Use of Antipsychotics in Attention-Deficit Hyperactivity Disorder. Korean College of Neuropsychopharmcology, establishment 11-17.
5 E. Y. Oh, et al. (2000). Comparison of Therapeutic Efficacy between Haloperidol and Risperdone in Tic Disirders. Korean College of Neuropsychopharmcology, 11(3), 270-277.
6 N. Ji & R. L. Findling. (2015). Anupdate on pharmacotherapy for autism Spectrum Disorder in Children and Adolescents. Curr Opin Psychiatry, 28(2), 91-101.   DOI
7 J. S. Choi. (1993). Pharmacological Treatment in pervasive developmental disorders. J. the Korean Academy of Child and Adolescent Psychiatry. 4(1), 27-38.
8 T. Hayashi et al. (2004). Actual Conditions of Use of Anti-Psychotic Drugs in Institute for People with Intellectual Disabilities. Bulletin of the School of Nursing, Yamaguchi Prefectural University, 8, 1-4.
9 Y. Ono. (2000). Usage status of psychotropic medication in Mental retardation. Clinical psychiatry, 47(7), 697-703.
10 N. D. Goli et al. (2016). Intellectual Disability in Children; a Systematic Review. Quarterly of International Archives of Health Sciences. 3(2), 27-36.   DOI
11 H. Nakayama. (2001). A Questionnaire survey on the psychiatric conditions of patients in residential facilities for mentally handicapped children. Japanese Journal of Child and Adolescent Psychiatry. 42(1), 57-65.
12 K. Tanaka et al. (2006). Clinical Characteristics and Pharmacotherapy of Extremely Disruptive Behavior Disorders in People with Mental Retardation. No To Hattatsu, 38, 19-24.
13 M, Weiss et. al. (2009). A naturalistic study of predictors and risks of atypical antipsychotic use in an attention-deficit/hyperactivity disorder clinic. J Child Adolesc Psychopharmacol, 19, 575-582.   DOI
14 H. J. Yu. (2018). The clinical approach of mental health to the socially underprivileged such as developmnetal disability etc. Classroon of a psychiatrist in Seoul National University, SHUBH, The psychiatry department, presentation material.
15 M. S. Kim & H. J., Kim. (2011). Understand and Education of Special Children for Special Education Teacher. Changjisa. 140-146.
16 D. L. Bowring et al. (2017). Challenging behaviors in adults with intellectual disability: A total poupulation study and exploration of risk indices. Br J Clin Psychol. 56(1). 16-32   DOI
17 J. Y. Kwon. (2009). Diagnostic Evaluation and Rehabilitation in Children with Intellectual Disabilities. Korean Med Assoc. 52(6), 601-610.   DOI
18 M. Y. Choi. (2009). Health and Medical Care for People With Disability. Health And welfare Forum, 46-63.
19 S. B. Lee et. al. (2016). Differences of obstetric complications and clinical characteristics between autism spectrum disorder and Intellectual Disability. Psychosmatic, 24(2), 165-173.
20 E. Y. Oh et. al. (2013). Comparison of Therapeutic Efficacy between Haloperidol and Risperidone in Tic Disorders. The Korean Journal of Psychopharmacology, 11(3), 270-277
21 H. W. Sin. (2011). Recognition of the importance and practice of the assessment of rehabilitation services and therapeutic facilities for disables person. Unpublished master's dissertation, Kwangwoon University.
22 H. K. Lim(2014). Social Worker's perception of minimum service standards of residental care facilities for the disabled. Unpublished master's dissertation, Ulsan University.
23 Y. I. Chung & S. H. Park. (2006). Development History of Antipsychotic Drugs. The Korean Journal of Psychopharmacology, 17(3), 283-290.
24 S. K. Park.(2016). The present condition and tasks of deinstitutionalization of the people with disabilities in Korea. Journal of Intellectual Disabilities, 18(1), 205-234.
25 Y. Inoue et al. (2016). Psychotropic Prescribing Practices for Children and Adolescents with Intellectual Disabilities : A cohort Study Using a Large-Scale Health Insurance Database. Psychiat. neurol. Jap, 118(11), 823-833.
26 Japanese Association on intellectual & Welfare Disabilities. (2016). National Intellectual Disabilities Report on actual condition of entrance facility. 235-295.
27 T. Doan et. al. (2014). Psychotropic medication use in adolescents with intellectual disability living in the community. Pharmacoepidemiol Drug Saf, 23(1), 69-76.   DOI
28 I. Kimura et. al.(2016). Treatment for self-injurious in mentally hadicapped populatons -a report from our practice. Hattatsu, 48, 117-121.
29 S. W, Hsu er. al. (2014). Trends in the use of psychotropic drugs in people with intellectual disability in Taiwan: a nationwide outpatient service study, 1997-2007. Res Dev Disabil., 35(2), 364-372.   DOI
30 J. S. Kwon & K. J. Lee. (2004). Atypical Antipsychotics : The Benefit and Disadvantage. Korean J Psychopharmacol, 15(2), 125-134.
31 J. W. Park & H. Y. Im.(1993). The Experiences of Antipsychotic Agents in Mentally Disabled. Korean J Str Res, 20, 21-30.